MedPath

上海朝晖药业有限公司

Ownership
-
Established
1988-03-23
Employees
-
Market Cap
-
Website
http://www.zhpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

79

NMPA:79

Drug Approvals

去氧氟尿苷胶囊

Product Name
可弗
Approval Number
国药准字H20020332
Approval Date
Aug 19, 2024
NMPA

万宝油

Approval Number
国药准字Z20194104
Approval Date
Jun 12, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20243508
Approval Date
Apr 17, 2024
NMPA

马来酸氨氯地平

Approval Number
国药准字H20020418
Approval Date
Mar 15, 2024
NMPA

Fasudil Hydrochloride Injection

Product Name
盐酸法舒地尔注射液
Approval Number
国药准字H20193113
Approval Date
Feb 26, 2024
NMPA

美洛昔康

Approval Number
国药准字H20020290
Approval Date
Sep 21, 2023
NMPA

去氧氟尿苷

Approval Number
国药准字H20020331
Approval Date
Sep 21, 2023
NMPA

硝酸益康唑乳膏

Approval Number
国药准字H31021095
Approval Date
Feb 10, 2023
NMPA

盐酸苯海拉明

Approval Number
国药准字H31021050
Approval Date
Jan 12, 2023
NMPA

硝酸益康唑

Approval Number
国药准字H31021048
Approval Date
Jan 12, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.